NutraVita Glucosamine 1500mg Powder

Move With Ease, Live With Comfort

NutraVita Glucosamine 1500mg Powder

High-strength 1500mg glucosamine that improves osteoarthritis, relieves joint pain, improves mobility and flexibility.

Buy now

Suitable for

Individuals with osteoarthritis

Glucosamine is used as an adjuvant therapy for osteoarthritis that reduces symptoms such as joint pain, stiffness, changes in mobility.

Individuals who suffer from joint pain, joint stiffness and swelling

Glucosamine reduces joint pain and improves joint function by increasing the production of cartilage and delaying the breakdown of cartilage.

Individuals who experience difficulties in mobility due to joint discomfort

Glucosamine relieves joint discomfort and improves mobility.

What is Osteoarthritis?

Osteoarthritis is a common condition that affects the joints in your body. It’s a type of arthritis that happens when the protective cartilage that cushions the joints starts to wear away. This can lead to pain, stiffness and difficulty moving around. As the cartilage wears away, bone rubs against bone and this can cause more damage.

Some common symptoms of osteoarthritis are:

  • Pain or aching in a joint
  • Stiffness in a joint, especially in the morning or after sitting for a long time
  • Limited movement in a joint
  • Grating or crackling sensation when using the joint
  • Swelling or tenderness in a joint

Research Studies

Visual Portfolio, Posts & Image Gallery for WordPress

Jörg Jerosch, 2011

Glucosamine is a basic component of our cartilage and synovial fluid It stimulates the formation of cartilage that leads to regeneration of the joint structure It slows down the progression of cartilage destruction It has anti-inflammatory properties that delay the breakdown of cartilage that is caused by inflammation

Reference:

  1. Al-Saadi, H. M., Pang, K. L., Ima-Nirwana, S., & Chin, K. Y. (2019). Multifaceted protective role of glucosamine against osteoarthritis: review of its molecular mechanisms. Scientia Pharmaceutica, 87(4), 34.
  2. Centers for Disease Control and Prevention. (2020). Osteoarthritis. U.S Department of Health & Human Services. https://www.cdc.gov/arthritis/basics/osteoarthritis.htm#:~:text=Osteoarthritis%20(OA)%20is%20the%20most,underlying%20bone%20begins%20to%20change.
  3. Jerosch J. (2011). Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. International journal of rheumatology, 2011, 969012. https://doi.org/10.1155/2011/969012
  4. Gregori, D., Giacovelli, G., Minto, C., Barbetta, B., Gualtieri, F., Azzolina, D., Vaghi, P., & Rovati, L. C. (2018). Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis. JAMA, 320(24), 2564–2579. https://doi.org/10.1001/jama.2018.19319
Next Project